Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
256 hedge funds and large institutions have $3.06B invested in Inari Medical, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 92 increasing their positions, 87 reducing their positions, and 33 closing their positions.
138% more call options, than puts
Call options by funds: $20.1M | Put options by funds: $8.41M
36% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 33
9% more capital invested
Capital invested by funds: $2.81B → $3.06B (+$253M)
4% more funds holding
Funds holding: 246 → 256 (+10)
6% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 87
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$161M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$63.7M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$33.1M |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$29.8M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$24.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$84.8M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$37M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$27.9M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$21.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$19.7M |
NARI Hedge Fund Activity: Q1 2023 in Review
256 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q1 2023, worth a combined $3.06B — up 9% from $2.81B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new NARI positions and 33 closed out — a net gain of 12 holders — while 92 added to existing stakes and 87 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $161M. The largest seller was Macquarie Group, cutting an estimated $84.8M.
- 256 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q1 2023, up from 246 in Q4 2022.
- Funds reported $3.06B of Inari Medical, Inc. Common Stock stock for Q1 2023, up 9% quarter-over-quarter.
- 45 funds opened new Inari Medical, Inc. Common Stock positions in Q1 2023 and 33 closed out, a net change of +12 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q1 2023 was Point72 Asset Management, an estimated $161M added.
- The largest Inari Medical, Inc. Common Stock seller in Q1 2023 was Macquarie Group, an estimated $84.8M sold.
Based on aggregated 13F filings for Q1 2023.